Streetbeat News

Analyst Ratings

EYPT

Mizuho analyst Graig Suvannavejh maintains a Buy rating on EyePoint Pharmaceuticals (NASDAQ:EYPT) and raises the price target from $30 to $39.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:48 pm

AXSM

Mizuho analyst Graig Suvannavejh maintains a Buy rating on Axsome Therapeutics (AXSM) and raises the price target from $90 to $112.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:48 pm

CERE

Mizuho analyst Graig Suvannavejh maintains a Neutral rating on Cerevel Therapeutics Hldg (NASDAQ:CERE) and raises the price target from $25 to $45.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:48 pm

APLS

Mizuho analyst Graig Suvannavejh has maintained a Neutral rating on Apellis Pharmaceuticals (NASDAQ:APLS) and increased the price target from $49 to $60.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 11:48 pm

BTCUSD

META

NVDA

TSLA

Bitcoin surpassed $50,000, reaching a $1-trillion market valuation after SEC approval for a Bitcoin ETF. Nvidia outpaced Amazon and Alphabet, becoming the third-largest U.S. company. Inflation reports led to reassessment of Fed rate cuts, affecting tech stocks. AI investment is predicted to reach $1 trillion in 10 years, with Nvidia at the forefront. Tesla's stock may rise due to stable pricing and Full Self-Driving adoption. The top seven U.S. tech giants' stocks surged 140%, raising bubble concerns. Wealth migration to tax-favorable states is noted, and Zuckerberg praised Meta's Quest 3 over Apple's Vision Pro.

Portfolio Pulse from Piero Cingari

February 16, 2024 | 9:29 pm

WDAY

Smart money investors have shown a predominantly bearish stance on Workday (NASDAQ:WDAY), with 75% of detected options trades being bearish. The trades range between bullish and bearish sentiments, with a notable volume in calls and puts indicating a price target range from $200.0 to $410.0. Workday, a cloud software company, has seen its stock price increase by 0.5% to $306.63, with an upcoming earnings report in 10 days. Industry analysts have set an average target price of $326.5 for WDAY, with specific targets from BMO Capital and JMP Securities at $338 and $315, respectively.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 8:54 pm

V

Financial analysts have observed a predominantly bearish sentiment among big money traders on Visa (NYSE:V), with 80% of unusual trades showing bearish tendencies. Analysis of options history revealed 20 unusual trades, with a focus on a price band between $120.0 and $370.0. Despite this, Visa remains a dominant player in the payment processing industry, with over $14 trillion processed in fiscal 2022. The stock's current price is slightly down, and analysts have set an average price target of $296.0, with ratings ranging from Neutral to Buy.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 8:54 pm

SUM

Summit Materials' stock price increased following RBC Capital's decision to maintain a Sector Perform rating while raising its price target from $38 to $39.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 8:54 pm

CLBT

Cellebrite DI's stock (CLBT) is trading higher following an upgrade from B of A Securities, moving from Neutral to Buy, with a new price target set at $12.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 8:54 pm

DE

Deutsche Bank analyst Nicole Deblase has maintained a Hold rating on Deere & Co. (DE) and lowered the price target from $425 to $401.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 8:54 pm